The forecasted re-import of sulphonamides to Canada remains stable over the next five years, with values remaining between 6.46 and 6.47 thousand US dollars annually. This indicates minimal change compared to the projected figures for 2023, suggesting a stagnancy in the re-import market for this class of antibiotics.

Given the negligible percentage change year-on-year from 2024 to 2028, we can infer a lack of growth dynamics over this period. Given the stable outlook, the compound annual growth rate (CAGR) is effectively zero.

Future factors to observe include potential changes in global production capacities.
Trade policy adjustments between Canada and its trading partners could affect re-import levels.
Developments in alternative treatments influencing demand for sulphonamides.
Any regulatory changes affecting the import of pharmaceutical ingredients.